Josh Vogel
Vice President of Investor Relations
Replay available
Cross Country Healthcare, Inc. (NASDAQ: CCRN) Q2 2024 earnings conference call, held 2024-07-31. Replay captured from the company's public earnings webcast.

Vice President of Investor Relations
President and Chief Executive Officer
Chief Financial Officer
Analyst, Bank of America
Analyst, William Blair
Analyst, Jefferies
Analyst, UBS
Group President of Delivery
Analyst, Benchmark Company
Analyst, Truist
Unknown
Analyst, JMP
Analyst, Barrington Research
afternoon, everyone. Welcome to Cross Country Healthcare's earnings conference call for the second quarter 2024. Please be advised that this call is being recorded and a replay of this webcast will be available on the company's website. Details for accessing the audio replay can be found in the company's earnings release issued this afternoon. At the conclusion of the prepared remarks, I will open the lines for questions. I would now like to turn the call over to Josh Vogel, Cross Country Healthcare's Vice President of Investor Relations. Thank you, and please go ahead, sir. Thank you, and good afternoon, everyone. I'm joined today by our President and Chief Executive Officer, John Martins, as well as Bill Burns, our Chief Financial Officer, and Mark Krug, Group President of Delivery. Today's call will include a discussion of our financial results for the second quarter of 2024, as well as our outlook for the third quarter. A copy of our earnings press release is available on our website at crosscountry.com. Please note that certain statements made on this call may constitute forward-looking statements. These statements reflect the company's beliefs based upon information currently available to it. As noted in our press release, forward-looking statements can vary materially from actual results and are subject to known and unknown risks, uncertainties, and other factors, including those contained in the company's 2023 annual report on Form 10-K and quarterly reports on Form 10-Q, as well as in other filings with the SEC. The company does not intend to update guidance or any of its forward-looking statements prior to the next earnings release. Additionally, we reference non-GAAP financial measures such as adjusted EBITDA or adjusted earnings per share. Such non-GAAP f...